Metlife (MET) closed at $102.89 on November 4, 2026, up 2.2% from the previous close, on volume of 4,731,693 shares (30-day average 3,052,872).
Data as of November 4, 2026.
MetLife Reports Strong Third-Quarter 2026 Financial Results
TipRanks (Wed, 4-Nov 5:33 PM ET)
MetLife CFO John McCallion Provides Third Quarter 2026 Financial Update Video
Business Wire (Wed, 4-Nov 4:20 PM ET)
MetLife Non-GAAP EPS of $2.85 beats by $0.08, revenue of $20.52B beats by $550M
Seeking Alpha News (Wed, 4-Nov 4:18 PM ET)
MetLife Announces 3Q 2026 Results
Business Wire (Wed, 4-Nov 4:15 PM ET)
BofA adds TMUS, REGN to Value 10 list, leaves Growth 10 untouched
Seeking Alpha News (Wed, 4-Nov 11:42 AM ET)
Here are the major earnings after the close Wednesday
Seeking Alpha News (Wed, 4-Nov 10:00 AM ET)
MetLife Q3 2026 Earnings Preview
Seeking Alpha News (Tue, 3-Nov 5:35 PM ET)
Financials Q3 earnings roundup: Payment giants lead a week of EPS beats
Seeking Alpha News (Fri, 30-Oct 10:20 AM ET)
MetLife CEO and CFO to Speak at the J.P. Morgan Financials Conference
Business Wire (Thu, 29-Oct 4:15 PM ET)
Business Wire (Wed, 14-Oct 8:00 AM ET)
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: group benefits, retirement and income solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Investment Managenent. Group Benefits and RIS are US-based, contributing to around 52% of the firm's 2025 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 14% of 2024 earnings. The EMEA and investment management segments contributed around 6% and 3% of 2025 earnings, respectively.
Metlife trades on the NYSE stock market under the symbol MET.
As of November 4, 2026, MET stock price climbed to $102.89 with 4,731,693 million shares trading.
MET has a beta of 0.74, meaning it tends to be less sensitive to market movements. MET has a correlation of 0.15 to the broad based SPY ETF.
MET has a market cap of $65.38 billion. This is considered a Large Cap stock.
Last quarter Metlife reported $19 billion in Revenue and $2.43 earnings per share. This fell short of revenue expectation by $-563 million and exceeded earnings estimates by $.06.
In the last 3 years, MET traded as high as $103.65 and as low as $58.89.
The top ETF exchange traded funds that MET belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
MET has outperformed the market in the last year with a price return of +34.5% while the SPY ETF gained +13.3%. MET has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +8.7% and +2.3%, respectively, while the SPY returned +1.5% and -0.3%, respectively.
MET support price is $99.18 and resistance is $102.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MET shares will trade within this expected range on the day.